|
|
|
Volumn 7, Issue 2, 1993, Pages 139-165
|
|
Ethnic and racial differences in response to medicines: Preserving individualized therapy in managed pharmaceutical programmes
|
|
Author keywords
cost containment; economics; formularies; genetic polymorphism; medicines; metabolism; pharmacogenetics; therapy
|
|
Indexed keywords
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
ANTINEOPLASTIC AGENT;
ANXIOLYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CAFFEINE;
CARDIOVASCULAR AGENT;
CHLORPROMAZINE;
CLOMIPRAMINE;
CLONAZEPAM;
DEBRISOQUINE;
DESIPRAMINE;
DIAZEPAM;
IMIPRAMINE;
IMMUNOSUPPRESSIVE AGENT;
NEUROLEPTIC AGENT;
NITRAZEPAM;
NORTRIPTYLINE;
OPIATE;
PERPHENAZINE;
PHENELZINE;
SPARTEINE;
THIORIDAZINE;
TUBERCULOSTATIC AGENT;
UNINDEXED DRUG;
ACETYLATOR PHENOTYPE;
COST CONTROL;
CULTURAL FACTOR;
DRUG FORMULARY;
DRUG METABOLISM;
DRUG RESPONSE;
ECONOMIC ASPECT;
ENVIRONMENTAL FACTOR;
ETHNIC DIFFERENCE;
GENETIC POLYMORPHISM;
HUMAN;
PHARMACOGENETICS;
RACE DIFFERENCE;
REVIEW;
|
|
EID: 0027191249
PISSN: 02650673
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (0)
|
